Picture of ReproCELL Incorporated logo

4978 — ReproCELL Incorporated News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Table: Reprocell - 9-MTH group results

Feb 10 (Reuters)- 
             Reprocell Incorporated 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to  
                Dec 31, 2022        Dec 31, 2021      Mar 31, 2023 
                   LATEST             YEAR-AGO           LATEST    
                   RESULTS             RESULTS          FORECAST   
  Sales             2.22                1.49              2.48     
                 (+49.4 pct)         (+56.8 pct)      (+10.8 pct)  
  Operating     loss 207 mln        loss 529 mln      loss 280 mln 
  Recurring      loss 36 mln        loss 351 mln      loss 136 mln 
  Net            loss 39 mln        loss 351 mln      loss 136 mln 
  EPS           loss 0.47 yen       loss 4.74 yen    loss 1.66 yen 
  Ann Div                                NIL              NIL      
  -Q2 div            NIL                 NIL                       
  -Q4 div                                NIL              NIL      
  
  NOTE - Reprocell Incorporated. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4978.T

Recent news on ReproCELL Incorporated

See all news